Literature DB >> 16194283

Does provider adherence to a treatment guideline change clinical outcomes for patients with bipolar disorder? Results from the Texas Medication Algorithm Project.

Ellen B Dennehy1, Trisha Suppes, A John Rush, Alexander L Miller, Madhukar H Trivedi, M Lynn Crismon, Thomas J Carmody, T Michael Kashner.   

Abstract

BACKGROUND: Despite increasing adoption of clinical practice guidelines in psychiatry, there is little measurement of provider implementation of these recommendations, and the resulting impact on clinical outcomes. The current study describes one effort to measure these relationships in a cohort of public sector out-patients with bipolar disorder.
METHOD: Participants were enrolled in the algorithm intervention of the Texas Medication Algorithm Project (TMAP). Study methods and the adherence scoring algorithm have been described elsewhere. The current paper addresses the relationships between patient characteristics, provider experience with the algorithm, provider adherence, and clinical outcomes. Measurement of provider adherence includes evaluation of visit frequency, medication choice and dosing, and response to patient symptoms. An exploratory composite 'adherence by visit' score was developed for these analyses.
RESULTS: A total of 1948 visits from 141 subjects were evaluated, and utilized a two-stage declining effects model. Providers with more experience using the algorithm tended to adhere less to treatment recommendations. Few patient factors significantly impacted provider adherence. Increased adherence to algorithm recommendations was associated with larger decreases in overall psychiatric symptoms and depressive symptoms over time, but did not impact either immediate or long-term reductions in manic symptoms.
CONCLUSIONS: Greater provider adherence to treatment guideline recommendations was associated with greater reductions in depressive symptoms and overall psychiatric symptoms over time. Additional research is needed to refine measurement and to further clarify these relationships.

Entities:  

Mesh:

Year:  2005        PMID: 16194283     DOI: 10.1017/S0033291705005933

Source DB:  PubMed          Journal:  Psychol Med        ISSN: 0033-2917            Impact factor:   7.723


  11 in total

1.  Use of psychotropic medication guidelines at child-serving community mental health centers as assessed by clinic directors.

Authors:  Jack Stevens; Kelly J Kelleher; Wei Wang; Sonja K Schoenwald; Kimberly E Hoagwood; John Landsverk
Journal:  Community Ment Health J       Date:  2010-09-29

Review 2.  Assessing physicians' use of treatment algorithms: Project IMPACTS study design and rationale.

Authors:  Madhukar H Trivedi; Cynthia A Claassen; Bruce D Grannemann; T Michael Kashner; Thomas J Carmody; Ella Daly; Janet K Kern
Journal:  Contemp Clin Trials       Date:  2006-08-16       Impact factor: 2.226

Review 3.  Utilization of collaborative practice agreements between physicians and pharmacists as a mechanism to increase capacity to care for hematopoietic stem cell transplant recipients.

Authors:  Julianna A Merten; Jamie F Shapiro; Alison M Gulbis; Kamakshi V Rao; Joseph Bubalo; Scott Lanum; Ashley Morris Engemann; Sepideh Shayani; Casey Williams; Helen Leather; Tracey Walsh-Chocolaad
Journal:  Biol Blood Marrow Transplant       Date:  2013-02-15       Impact factor: 5.742

4.  Adherence of psychopharmacological prescriptions to clinical practice guidelines in patients with eating behavior disorders.

Authors:  María Del Mar Alañón Pardo; Mónica Ferrit Martín; Miguel Ángel Calleja Hernández; Francisco Morillas Márquez
Journal:  Eur J Clin Pharmacol       Date:  2017-06-26       Impact factor: 2.953

5.  A medication assessment tool to evaluate prescribers' adherence to evidence-based guidelines in bipolar disorder.

Authors:  Dalal M Al-Taweel; Mohammad Alsuwaidan
Journal:  Int J Clin Pharm       Date:  2017-06-26

Review 6.  New drugs for bipolar disorder.

Authors:  Marsal Sanches; Jair C Soares
Journal:  Curr Psychiatry Rep       Date:  2011-12       Impact factor: 5.285

7.  Medication burden in bipolar disorder: a chart review of patients at psychiatric hospital admission.

Authors:  Lauren M Weinstock; Brandon A Gaudiano; Gary Epstein-Lubow; Katherine Tezanos; Cintly E Celis-Dehoyos; Ivan W Miller
Journal:  Psychiatry Res       Date:  2014-02-01       Impact factor: 3.222

8.  Guidelines disconcordance in acute bipolar depression: data from the national Bipolar Mania Pathway Survey (BIPAS) in mainland China.

Authors:  Zuowei Wang; Keming Gao; Wu Hong; Mengjuan Xing; Zhiguo Wu; Jun Chen; Chen Zhang; Chengmei Yuan; Jia Huang; Daihui Peng; Yong Wang; Weihong Lu; Zhenghui Yi; Xin Yu; Jingping Zhao; Yiru Fang
Journal:  PLoS One       Date:  2014-04-24       Impact factor: 3.240

9.  Pharmacotherapy for acute mania and disconcordance with treatment guidelines: bipolar mania pathway survey (BIPAS) in mainland China.

Authors:  Zuowei Wang; Keming Gao; Wu Hong; Mengjuan Xing; Zhiguo Wu; Jun Chen; Chen Zhang; Chengmei Yuan; Jia Huang; Daihui Peng; Yong Wang; Weihong Lu; Zhenghui Yi; Xin Yu; Jingping Zhao; Yiru Fang
Journal:  BMC Psychiatry       Date:  2014-06-05       Impact factor: 3.630

10.  Pharmacotherapy for bipolar disorder and concordance with treatment guidelines: survey of a general population sample referred to a tertiary care service.

Authors:  Sabrina Paterniti; Jean-Claude Bisserbe
Journal:  BMC Psychiatry       Date:  2013-08-13       Impact factor: 3.630

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.